-
-
-
-
-
-
-
BioCardia reports trial shows cell therapy improves heart symptoms
-
-
-
-
-
-
-
BioCardia (BCDA) Misses Q3 EPS by 24c
-
-
-
-
-
-
-
BioCardia (BCDA) Announces New United States Patent for Helix Biotherapeutic Delivery System
-
-
-
-
-
-
-
BioCardia (BCDA) announce completed low dose enrollment for CardiALLO phase I/II
-
-
-
-
-
-
-
BioCardia (BCDA)" FDA Approves CardiAMP Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment
-
-
-
-
479,039 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


